These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37457135)

  • 41. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
    Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
    Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components.
    Hsu SK; Jadhao M; Liao WT; Chang WT; Hung CT; Chiu CC
    Front Mol Biosci; 2022; 9():1020888. PubMed ID: 36299300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
    Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.
    Herting CJ; Karpovsky I; Lesinski GB
    Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Takahashi R; Macchini M; Sunagawa M; Jiang Z; Tanaka T; Valenti G; Renz BW; White RA; Hayakawa Y; Westphalen CB; Tailor Y; Iuga AC; Gonda TA; Genkinger J; Olive KP; Wang TC
    Gut; 2021 Feb; 70(2):330-341. PubMed ID: 32393543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
    Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
    Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
    Tassone E; Muscolini M; van Montfoort N; Hiscott J
    Cytokine Growth Factor Rev; 2020 Dec; 56():141-148. PubMed ID: 32859494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
    Ahmad RS; Eubank TD; Lukomski S; Boone BA
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fungi, host immune response, and tumorigenesis.
    Elaskandrany M; Patel R; Patel M; Miller G; Saxena D; Saxena A
    Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G213-G222. PubMed ID: 34231392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma.
    Lee HK; Nam MW; Go RE; Koo J; Kim TH; Park JE; Choi KC
    Biomed Pharmacother; 2023 Mar; 159():114212. PubMed ID: 36610224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
    Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.
    Lafaro KJ; Melstrom LG
    Am J Pathol; 2019 Jan; 189(1):44-57. PubMed ID: 30558722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.
    Wu TC; Liao CY; Lu WC; Chang CR; Tsai FY; Jiang SS; Chen TH; Lin KM; Chen LT; Chang WW
    J Exp Clin Cancer Res; 2022 Apr; 41(1):137. PubMed ID: 35410237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How does the tumor microenvironment play a role in hepatobiliary tumors?
    Kamil F; Rowe JH
    J Gastrointest Oncol; 2018 Feb; 9(1):180-195. PubMed ID: 29564184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21.
    Lin X; Ye L; Wang X; Liao Z; Dong J; Yang Y; Zhang R; Li H; Li P; Ding L; Li T; Zhang W; Xu S; Han X; Xu H; Wang W; Gao H; Yu X; Liu L
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.